Histone deacetylase inhibitor MGCD0103 synergizes with gemcitabine in human pancreatic cells. - Wikidata - awgldk - TriplyDB

Histone deacetylase inhibitor MGCD0103 synergizes with gemcitabine in human pancreatic cells.

Histone deacetylase inhibitor MGCD0103 synergizes with gemcitabine in human pancreatic cells.

http://www.wikidata.org/entity/Q39581269

about

Role of histone deacetylases in pancreas: Implications for pathogenesis and therapy Disruption of autophagy by the histone deacetylase inhibitor MGCD0103 and its therapeutic implication in B-cell chronic lymphocytic leukemia.Class I and class II histone deacetylases are potential therapeutic targets for treating pancreatic cancer New targeted therapies in pancreatic cancer.ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat.Overcoming nucleoside analog chemoresistance of pancreatic cancer: a therapeutic challenge.Metabolic changes in rats after intragastric administration of MGCD0103 (Mocetinostat), a HDAC class I inhibitor.Mocetinostat combined with gemcitabine for the treatment of leiomyosarcoma: Preclinical correlates.Phase I/II study of mocetinostat in combination with gemcitabine for patients with advanced pancreatic cancer and other advanced solid tumors.Panobinostat as Pan-deacetylase Inhibitor for the Treatment of Pancreatic Cancer: Recent Progress and Future Prospects.

P2860

Q26774080-761F920E-37AE-4164-8835-F76D815EBD54 Q34038766-DAF21C28-1794-44EB-8C35-94F617FD2DD1 Q34318452-FFBD55E0-0EC7-42FB-9814-E551813D6B56 Q35651453-75D6BBB6-8330-4832-9D97-F8E631813326 Q35695410-F70EEB85-4E06-4AB7-88C3-38500D22E485 Q37994505-47CC93D9-D44D-4E0F-B750-822A66B40FC5 Q43092116-5D7F0A69-917C-4404-AE34-E9EA57074E88 Q47130359-B9F6CEF2-10A7-4EDE-A212-C96EDD8CDD69 Q49853764-5A198883-136A-4CAA-B058-727F52781DB2 Q51034578-0A1E8711-6C5F-4426-9D2F-20446D45E735

P2860

Histone deacetylase inhibitor MGCD0103 synergizes with gemcitabine in human pancreatic cells.

http://www.wikidata.org/entity/Q39581269

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Histone deacetylase inhibitor ...... ine in human pancreatic cells.

@en

Histone deacetylase inhibitor ...... ine in human pancreatic cells.

@nl

type

label

Histone deacetylase inhibitor ...... ine in human pancreatic cells.

@en

Histone deacetylase inhibitor ...... ine in human pancreatic cells.

@nl

prefLabel

Histone deacetylase inhibitor ...... ine in human pancreatic cells.

@en

Histone deacetylase inhibitor ...... ine in human pancreatic cells.

@nl

P1433

Q39581269-7F20C233-BCEF-46A3-A2CF-CD4603356A5A

P1476

Q39581269-7C75A7DC-1AEF-4D1C-BEC4-F790975C87CE

P2093

Q39581269-2381F115-5070-498D-9987-4D213A95F0DA

Q39581269-541DB330-9990-4B13-9167-3A899A69F290

Q39581269-5D5A98AD-0E26-4550-98A5-FB610599144B

Q39581269-9AF27279-8430-4EAB-A338-4E924871DA4F

Q39581269-A0FAC7D6-F467-450B-B6AB-77745DC02899

Q39581269-ACA32653-3108-4243-8B88-685DBEA509D3

P2860

Q39581269-0069799F-A0AC-4CD1-8A40-B0C0F852D1F0

Q39581269-01C80707-6595-433C-AAE1-D0A2CC4EBEC7

Q39581269-1494284C-3021-447E-AFDC-6A7AAA1ECE89

Q39581269-167DA07E-7F85-43B4-9939-9D7BAD0C0449

Q39581269-2470FFC0-AED8-4781-AFF5-3055FBC2E990

Q39581269-290697C4-8903-4749-9ABA-5CE4E2BDA088

Q39581269-3030FBEB-A57C-46F3-8E2A-612C3702110E

Q39581269-42FF4480-DE40-4607-A97E-D9B440026F6B

Q39581269-460EB563-5F29-41A8-83B7-979D88258142

Q39581269-46840C72-7B2A-462D-89DE-908B928B280B

P304

Q39581269-859A09DE-4F1F-4477-B8FA-F69E3E3B16F7

P31

Q39581269-86850053-B2E2-4CE1-87CA-D8D314FBFC19

P356

Q39581269-02B8C81A-A1AF-4B84-8A5D-7CC9A6813C27

P433

Q39581269-9177EC19-8C7F-43E3-8598-5D6F7A8FAE89

P478

Q39581269-EA81915E-233A-489A-A382-A186E7B7F8F6

P577

Q39581269-8A47B272-455F-46CF-8BAA-98ECB5DA0A5A

P5875

Q39581269-D1036871-3099-467E-A9D8-A3A9125169A4

P698

Q39581269-D57AFC74-FE1A-416C-B09A-00F73B1FE38C

P356

J.1349-7006.2011.01921.X

P1433

P1476

Histone deacetylase inhibitor ...... ine in human pancreatic cells.

@en

P2093

Armin Maier

http://www.w3.org/2001/XMLSchema#string

Carla Heise

http://www.w3.org/2001/XMLSchema#string

Gerhard Kelter

http://www.w3.org/2001/XMLSchema#string

Helen Brady

http://www.w3.org/2001/XMLSchema#string

Normand Richard

http://www.w3.org/2001/XMLSchema#string

Victoria Sung

http://www.w3.org/2001/XMLSchema#string

P2860

Examination of the expanding pathways for the regulation of p21 expression and activity.

Chromatin modifications and their function

Anticancer activities of histone deacetylase inhibitors

p21 in cancer: intricate networks and multiple activities

Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.

Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia.

Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia.

Fibronectin, integrins, and growth control.

Evaluation of the pharmacodynamic effects of MGCD0103 from preclinical models to human using a novel HDAC enzyme assay.

Clinging to life: cell to matrix adhesion and cell survival.

P304

1201-1207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1349-7006.2011.01921.X

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50286909

http://www.w3.org/2001/XMLSchema#string

P698

21375679

http://www.w3.org/2001/XMLSchema#string